These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16724630)

  • 1. Immunomodulation in dermatology: lessons learned in the treatment of psoriasis.
    Charlesworth EN
    Allergy Asthma Proc; 2006; 27(2):123-5. PubMed ID: 16724630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What have we learned in dermatology from the biologic therapies?
    Nickoloff BJ; Stevens SR
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S143-51. PubMed ID: 16488330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in immunodermatology].
    Hautarzt; 1983; 34 Suppl 6():225-45. PubMed ID: 6678892
    [No Abstract]   [Full Text] [Related]  

  • 4. Psoriasis: a fresh look.
    Galadari I; Sharif MO; Galadari H
    Clin Dermatol; 2005; 23(5):491-502. PubMed ID: 16179183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Psoriasis, Therapies, and Suicide.
    Gooderham M; Gavino-Velasco J; Clifford C; MacPherson A; Krasnoshtein F; Papp K
    J Cutan Med Surg; 2016 Jul; 20(4):293-303. PubMed ID: 27207348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of biologic therapies for the treatment of psoriasis.
    Gordon KB; McCormick TS
    Skinmed; 2003; 2(5):286-94. PubMed ID: 14673261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of psoriasis: update on current and emerging treatment options.
    Leonardi CL
    Manag Care; 2003 May; 12(5 Suppl):3-9; discussion 20-1. PubMed ID: 18567143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoimmunology.
    Elmets CA; Cala CM; Xu H
    Dermatol Clin; 2014 Jul; 32(3):277-90, vii. PubMed ID: 24891051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alefacept: its safety profile, off-label uses, and potential as part of combination therapies for psoriasis.
    Scheinfeld N
    J Dermatolog Treat; 2007; 18(4):197-208. PubMed ID: 17671880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic agents in psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2006 Nov; 47(4):217-29; quiz 229-30. PubMed ID: 17034462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunologic revolution: photoimmunology.
    Ullrich SE; Byrne SN
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):896-905. PubMed ID: 22170491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of biologics in psoriasis: a review.
    Kim IH; West CE; Kwatra SG; Feldman SR; O'Neill JL
    Am J Clin Dermatol; 2012 Dec; 13(6):365-74. PubMed ID: 22967166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
    Krueger GG; Gottlieb AB; Sterry W; Korman N; Van De Kerkhof P
    J Dermatolog Treat; 2008; 19(3):146-55. PubMed ID: 18569270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in medical dermatology.
    Clark LN; Lebwohl M
    Int J Dermatol; 2007 Oct; 46(10):1005-10. PubMed ID: 17910704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in systemic psoriasis treatment therapies from 1993 through 2010.
    Shaw MK; Davis SA; Feldman SR; Fleischer AB
    J Drugs Dermatol; 2014 Aug; 13(8):917-20. PubMed ID: 25116968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Therapies for Psoriasis.
    Leonardi CL
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S71-3. PubMed ID: 27525355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Future perspectives in the treatment of psoriasis: news in biological therapies].
    Diamantino F; Ferreira A
    Acta Med Port; 2011; 24(6):997-1004. PubMed ID: 22713194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for treatment with anti-tumor necrosis factor agents in psoriasis: maintaining efficacy and safety for the long haul.
    Gordon KB; Gandhi M
    Arch Dermatol; 2010 Feb; 146(2):186-8. PubMed ID: 20157030
    [No Abstract]   [Full Text] [Related]  

  • 20. Considerations when initiating psoriasis patients on biologic therapy.
    Zeichner JA
    J Drugs Dermatol; 2012 May; 11(5 Suppl):s11-4. PubMed ID: 22644771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.